Stay updated on Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Locations section reorganized into a centralized master list, adding study sites across the United States, Canada, and Europe. Previously separate location entries (e.g., Arizona Locations, California Locations) were removed in favor of the consolidated Locations listing.
    Difference
    2%
    Check dated 2025-12-23T17:16:35.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    The Publications section now states that items are automatically filled in from PubMed, replacing the previous wording, and the page revision label was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-24T19:11:37.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The government funding/operating status notice banner was removed; study details, contacts, locations, and eligibility criteria remain unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T18:08:36.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected. The page content remains consistent with the study details.
    Difference
    0.3%
    Check dated 2025-11-03T12:48:19.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    1%
    Check dated 2025-10-05T17:39:56.000Z thumbnail image
  9. Check
    96 days ago
    Change Detected
    Summary
    Added version label v3.1.0 and removed several drug-safety topic sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs); overall shift appears to narrow scope and indicate an updated version rather than new safety content.
    Difference
    0.2%
    Check dated 2025-09-28T11:19:33.000Z thumbnail image

Stay in the know with updates to Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lebrikizumab with Topical Corticosteroid in Atopic Dermatitis Clinical Trial page.